Page last updated: 2024-10-22

alendronate and Barrett Epithelium

alendronate has been researched along with Barrett Epithelium in 1 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Research Excerpts

ExcerptRelevanceReference
"This study examined Barrett's esophagus (BE) risk factors in veterans to determine the association between risk of BE and use of oral bisphosphonates."1.39Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. ( Alsarraj, A; El-Serag, HB; Graham, DY; Kramer, JR; Lin, D; Parente, P; Ramsey, D; Rugge, M; Verstovsek, G, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, D1
Kramer, JR1
Ramsey, D1
Alsarraj, A1
Verstovsek, G1
Rugge, M1
Parente, P1
Graham, DY1
El-Serag, HB1

Other Studies

1 other study available for alendronate and Barrett Epithelium

ArticleYear
Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans.
    The American journal of gastroenterology, 2013, Volume: 108, Issue:10

    Topics: Aged; Alendronate; Barrett Esophagus; Bone Density Conservation Agents; Case-Control Studies; Diphos

2013